Koninklijke Philips | PHG - Operating Expenses


Koninklijke Philips reported EUR5.1B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Abbott USD 9.31B 104M Mar/2026
Baxter International USD 6.04B 2.85B Mar/2026
Becton, Dickinson and Co. USD 24.13B 19.54B Mar/2026
Boston Scientific USD 4.15B 107M Mar/2026
Danaher USD 52.95B 47.61B Mar/2026
Demant DKK 9.63B 241M Dec/2025
Dexcom USD 936.6M 0 Mar/2026
Edwards Lifesciences USD 1.13B 65.4M Mar/2026
Fresenius EUR 5.25B 337M Dec/2025
General Electric Aerospace USD 18.06B 7.11B Mar/2026
Getinge SEK 9.99B 2.3B Dec/2024
Globus Medical USD 595.85M 49.26M Mar/2026
GN Store Nord DKK 2.16B 1.94B Mar/2026
Hitachi JPY 2.71T 314.71B Mar/2026
Idexx Laboratories USD 778.23M 3.26M Mar/2026
Insulet USD 639.7M 2.2M Mar/2026
Integra LifeSciences USD 1.04B 673.49M Mar/2026
Intuitive Surgical USD 1.91B 89.8M Mar/2026
J&J USD 17.44B 1.53B Mar/2026
Koninklijke Philips EUR 5.1B 597.33M Dec/2025
Masimo USD 326.2M 2.4M Mar/2026
Medtronic USD 7.72B 436M Mar/2026
Philips EUR 3.6B 775M Mar/2026
ResMed USD 925.74M 525K Mar/2026
Smith & Nephew USD 2.52B 84M Dec/2025
Steris USD 1.27B 51.5M Mar/2026
Stryker USD 4.92B 284M Mar/2026
Teleflex USD 3.08B 2.55B Mar/2026
Terumo JPY 268.87B 16.12B Mar/2026
Zimmer Biomet Holdings USD 1.69B 249.3M Mar/2026